Innovation Technology of Subclinical Atherosclerosis Verification


This review article presents duplex scanning of carotid arteries as a key and the most informative modern noninvasive innovation technology for diagnostics of subclinical atherosclerosis. It was noted that during primary prophylaxis the values of intima-media complex of these arteries allow performing risk stratification of patients and selection of high-risk patients for aggressive lipid-lowering pharmacotherapy. 

Список литературы

1. World Health Organization. Research for universal health coverage: World health report 2013:168.

2. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD at al. Comparative Risk Assessment Collaborating Group. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 2004 Oct; 1(1):27. Published online 2004 Oct 19. doi:  10.1371/journal.pmed.0010027

3. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310–5.

4. Cross DS, McCarty CA, Hytopoulos E et al. Quertermous Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts. Curr Med Res Opin. 2012; 28(11):1819–30. doi:  10.1185/03007995.2012.742878

5. Ajani UA, Ford ES.  Has the risk for coronary heart disease changed among U.S. adults? J. Am. Coll. Cardiol. 2006; Vol.48(6):1177-1182. doi:  10.1016/J.jacc.2006.05.055

6. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. – 2008; Vol.117(4):25—146. doi:  10.1161/CIRCULATIONAHA.107.187998

7. Akosah KO, Shaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: How do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;(41):1475—9. doi: 10.1016/S0735-1097(03)00188-8

8. Conroy RM, Pyorala K, Fitzgerald AP, Sans S et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J. 2003;Vol. 24(11):987—1003. doi: 10.1016/S0195-668X(03)00114-3

9. Shalnova SA, Deev AD. Russian mortality trends in the early XXI century: official statistics data. Kardiovaskulyarnaya terapiya i profilaktika. 2011;(6):5-10. (In Russ.).

10. Boytsov SA, Karpov YuA, Kukharchuk VV et al. Identification of Patients at High Cardiovascular Risk: Problems and Possible Solutions. (Part I).Атеросклерозидислипидемии. 2010;Vol.1(1):8—14.

11. Hlatky MA, Greenland P, Arnett DK et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation. 2009; Vol. 119(17):2408-2416. doi:  10.1161/CIRCULATIONAHA.109.192278

12. Nordestgaard BG, Chapman MJ, Ray K et al. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;Vol.31(23):2844—2853. doi: 10.1093/eurheartj/ehq386

13. Shah T, Casas JP, Cooper JA,  Tzoulaki I et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. International Journal of Epidemiology. 2009;Vol.38(1):217—231. doi: 10.1093/ije/dyn217

14. von Reutern GM, Goertler MW, Bornstein NM et al. Grading Carotid Stenosis Using Ultrasonic Methods. Stroke. 2012;(43):916—21. doi:  10.1161/STROKEAHA.111.636084

15. Cobble M, Bale B. Carotid intima-media thickness: knowledge and application to everyday practice. Postgraduate medicine. 2010;122(1):7—15.

16. Mancia G, De Backer G, Dominiczak A. 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). EHJ. 2007;(28):1462—1536. doi:  10.1093/eurheartj/ehm236

16. Leng GC, Papacosta O, Whincup P et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000 Sep;152(1):167—74.

18.  Alexandrov AV. Ultrasound and angiography in the selection of patients for carotid endarterectomy. Curr Cardiol Rep. 2003;(5):141–7. doi: 10.1007/s11886-003-0082-4

19. Jahromi AS, Cinà CS, Liu Y et al. Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis: a systematic review and meta-analysis. J Vasc Surg. 2005;(41):962–72. doi:  10.1016/j.jvs.2005.02.044

20. Jaffer FA, O'Donnell CJ, Larson MG et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 2002;(22):849—854. doi:

21. Kuller L, Borhani N, Furberg C et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J. Epidemiol. 1994;(139):1164—1179. doi:

22. Balahonova TV, Zhernakova YuV, Kaveshnikov VS et al. The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk. Sistemnye gipertenzii. 2014;4(11):37—42. (In Russ.).

23. Mary J Roman, Naqvi T., Gardin JM et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. American Society of Echocardiography Report. Vasc. med. 2006;(11):201—211. doi:  10.1177/1358863x06070511

24. Eleid MF, Lester SJ, Wiedenbeck TL et al. Carotid ultrasound identifies high risk subclinical atherosclerosis in adults with low framingham risk scores. J. Am. Soc. Echocardiogr. 2010;23(8): 802—808.  doi: 10.1016/j.echo.2010.06.003.

25. Stein JH, Korcarz CE, Hurst RT et al. American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J. Am Soc Echocardiogr. 2008;21(2):93—111.

26. Pencina MJ, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;Vol. 27(2):157—172. doi:  10.1002/sim.2929

27. Bartelsa S, Francob AR, Rundek T. Carotid intima-media thickness (cIMT) and plaque from risk assessment and clinical use to genetic discoveries. Perspect. Med. 2012;Vol. 1(1):139–45. doi: 10.1016/j.permed.2012.01.006

28. Grau M, Subirana I, Agis D, Ramos R et al. Carotid intima-media thickness in the Spanish population: reference ranges and association with cardiovascular risk factors. Rev Esp Cardiol (Engl Ed). 2012;Vol. 65(12):1086—1093. doi:  10.1016/j.rec.2012.04.019

29. Sinning C, Wild PS, Echevarria FM et al. Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study) Am. J. Cardiol. 2011;Vol.107(12):1841—1847. doi: 10.1016/j.amjcard.2011.02.318

30. Chambless LE, Heiss G, Folsom AR et al. Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987—1993. Am J Epidemiol. 1997;(146):483—94.

31. Stein JS, Korcarz CE, Post WS. Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: Summary and Discussion of the American Society of Echocardiography Consensus Statement. Preventive Cardiology. Winter 2009:34–8.

32. Filippov AE, Obrezan AG, Pomogaybo BV, Bovtyushko PV. Risk assessment of clinical atherosclerosis complications by the estimation of common carotid and femoral arteries’ intima-media thickness. Ateroskleroz i dislipidemii. 2016;3(24):39—46. (In Russ.).

33. Nair SB, Malik R, Khattar RS. Carotid intima-media thickness: ultrasound measurement, prognostic value and role in clinical practice. Postgrad Med J. 2012;(88):694—9. doi:  10.1136/postgradmedj-2011-130214

34. Butina EK, Bochkareva EV. The significance of carotid arteries subclinical atherosclerosis for primary prophylaxis of cardiovascular diseases.   Review of the main international research. Ratsional'naya farmakoterapiya v kardiologii. 2016;12(5):558—566. (In Russ.). doi:  10.20996/1819-6446-2016-12-5-558-566

35. Nambi V, Chambless L, Folsom AR et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J. Am. Coll. Cardiol. 2010;Vol.55(15):1600—1607. doi:  10.1016/j.jacc.2009.11.075

36. Brunzell JD, Davidson M, Furberg CD et al. Lipoprotein Management in Patients With Cardiometabolic Risk. Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008;(31):811—822. doi:  10.2337/dc08-9018

37. Greenland P, Alpert JS, Beller GA et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2010;Vol.56(25):50—103. doi: 10.1016/j.jacc.2010.09.001

38. Natsional'nye rekomendatsii po kardiovaskulyarnoi profilaktike (2011). Kardiovaskularnaya terapia i profilaktika. 2011;10(6):46—7. (In Russ.).

39. Perk J, De BG, Gohlke H, Graham I et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;(33):1635—701. doi:  10.1093/eurheartj/ehs092

40. Perk J, De Backer G, Gohlke H et al. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts. Atherosclerosis. 2012;223:1–68. doi:  10.1016/j.atherosclerosis.2012.05.007

41. Howard G, Sharrett AR, Heiss G et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 1993;Vol. 24(9):1297—1304.

42. Lloyd-Jones DM, Leip EP, Larson MG et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;(113):791—798. doi: 10.1161/CIRCULATIONAHA.105.548206

43. Wittekoek ME, de Groot E, Prins MH et al. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis. 1999Oct;146(2):271—9.

44. Mookadam F, Moustafa SE, Lester SJ, Warsameet T. Subclinical atherosclerosis: evolving role of carotid intima-media thickness. Prev Cardiol. 2010;(13):186—97. doi:  10.1111/j.1751-7141.2010.00072

45. Grigoricheva EA, Volkova EG. Surrogate atherosclerosis markers in patients with stage I-II arterial hypertension. Kardiovaskulyarnaya terapiya i profilaktika. 2009; (8):15—19. (In Russ.).

46. Soroka NN, Ryzhak GA. Mediointimal hyperplasia of carotid artery as a predictor of atherosclerosis in old people: ultrasonic diagnostic availability. Uspekhi gerontologii. 2006;(19): 102–106. (In Russ).

47. O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999;40(1):14—22. doi:  10.1056/NEJM199901073400103

48. Fernandes VR, Polak JF, Edvardsen T et al. Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). J. Am. Coll. Cardiol. 2006;47(12):2420—2428. doi: 10.1016/j.jacc.2005.12.075

49. Lorenz MW, Schaefer C, Steinmetz H, Sitzer M. Is carotid intima-media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur. Heart J. 2010;Vol.31(16):2041—2048. doi:

Для цитирования

SimerzinVV, FatenkovOV, GagloevaIV, GalkinaMA, Molchanova ТE, Yunusova YuR. Innovation Technology of Subclinical Atherosclerosis Verification. Science & Innovations in Medicine. 2017;4(8):28—35.


Send an online application form to the publication